Hiscox Ltd Share Price London S.E.
Equities
HSX
BMG4593F1041
Property & Casualty Insurance
End-of-day quote
Other stock markets
|
||
- GBP | - |
08/05 | UBS raises Centrica to 'buy' from 'neutral | AN |
07/05 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 3.89B 4.93B 412B | Sales 2025 * | 4.27B 5.41B 452B | Capitalization | 3.8B 4.82B 403B |
---|---|---|---|---|---|
Net income 2024 * | 466M 591M 49.37B | Net income 2025 * | 500M 634M 52.97B | EV / Sales 2024 * | 1.11 x |
Net Debt 2024 * | 514M 652M 54.43B | Net Debt 2025 * | 514M 652M 54.43B | EV / Sales 2025 * | 1.01 x |
P/E ratio 2024 * |
8.16
x | P/E ratio 2025 * |
7.49
x | Employees | - |
Yield 2024 * |
2.9% | Yield 2025 * |
3.21% | Free-Float | 97.38% |
Latest transcript on Hiscox Ltd
Managers | Title | Age | Since |
---|---|---|---|
Hamayou Hussain
CEO | Chief Executive Officer | 51 | 22/16/22 |
Paul Cooper
DFI | Director of Finance/CFO | 52 | 12/22/12 |
Stéphane Flaquet
COO | Chief Operating Officer | - | 01/10/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 16/17/16 | |
Anne MacDonald
BRD | Director/Board Member | 68 | 20/15/20 |
Colin Keogh
BRD | Director/Board Member | 69 | 19/15/19 |
1st Jan change | Capi. | |
---|---|---|
+54.26% | 67.84B | |
+8.37% | 48.73B | |
+8.06% | 47.14B | |
+12.21% | 41.45B | |
+30.95% | 36.37B | |
+69.04% | 31.49B | |
+9.09% | 28.84B | |
+24.87% | 25.12B | |
-0.81% | 21.09B |
- Stock Market
- Equities
- HSX Stock
- HSX Stock